References
Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1 (2): 109–20
Webb MC, Compton F, Andrews PA, et al. Skin tumours posttransplantation: a retrospective analysis of 28 years experience at a single centre. Transplant Proc 1997; 29: 828–30
Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Safety 2000; 23 (2): 101–13
Kuijken I, Bouwes Bavinck JN. Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanisms. BioDrugs 2000; 14 (5): 319–29
Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611–6
Euvrard S, Kanitakis J, Chardonnet Y, et al. External anogenital lesions in organ transplant recipients. Arch Dermatol 1997; 133: 175–8
Greene MH. Malignant melanoma in renal transplant recipients. Lancet 1981; II: 1196–9
Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274–8
Farge D. Kaposi’s sarcoma in organ transplant recipients. Eur J Med 1993; 2: 339–43
Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi’s sarcoma after solid organ transplantation. J Clin Oncol 1997; 15: 2371–7
Rights and permissions
About this article
Cite this article
Organ transplant recipients have an increased risk of neoplastic skin diseases. Drugs Ther. Perspect 19, 11–13 (2003). https://doi.org/10.2165/00042310-200319010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200319010-00004